BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 15279066)

  • 21. Genetic and enzymatic basis for the differential expression of GM2 and GD2 gangliosides in human cancer cell lines.
    Yamashiro S; Ruan S; Furukawa K; Tai T; Lloyd KO; Shiku H; Furukawa K
    Cancer Res; 1993 Nov; 53(22):5395-400. PubMed ID: 8221677
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human monoclonal antibody to tumor-associated ganglioside GD2.
    Katano M; Saxton RE; Irie RF
    J Clin Lab Immunol; 1984 Nov; 15(3):119-26. PubMed ID: 6099419
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lysis of human tumor cell lines by canine complement plus monoclonal antiganglioside antibodies or natural canine xenoantibodies.
    Helfand SC; Hank JA; Gan J; Sondel PM
    Cell Immunol; 1996 Jan; 167(1):99-107. PubMed ID: 8548851
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ganglioside biosynthetic gene expression in experimental mouse brain tumors.
    Ecsedy JA; Manfredi MG; Yohe HC; Seyfried TN
    Cancer Res; 1997 Apr; 57(8):1580-3. PubMed ID: 9108463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Binding activities and antitumor properties of a new mouse/human chimeric antibody specific for GD2 ganglioside antigen.
    Alvarez-Rueda N; Leprieur S; Clémenceau B; Supiot S; Sébille-Rivain V; Faivre-Chauvet A; Davodeau F; Paris F; Barbet J; Aubry J; Birklé S
    Clin Cancer Res; 2007 Sep; 13(18 Pt 2):5613s-5620s. PubMed ID: 17875797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A murine monoclonal antibody detecting N-acetyl- and N-glycolyl-GM2: characterization of cell surface reactivity.
    Natoli EJ; Livingston PO; Pukel CS; Lloyd KO; Wiegandt H; Szalay J; Oettgen HF; Old LJ
    Cancer Res; 1986 Aug; 46(8):4116-20. PubMed ID: 3731079
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of N-glycolyated gangliosides in non-small-cell lung cancer using GMR8 monoclonal antibody.
    Hayashi N; Chiba H; Kuronuma K; Go S; Hasegawa Y; Takahashi M; Gasa S; Watanabe A; Hasegawa T; Kuroki Y; Inokuchi J; Takahashi H
    Cancer Sci; 2013 Jan; 104(1):43-7. PubMed ID: 23004020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of the expression of N-glycolylneuraminic acid-containing gangliosides in cells and tissues using two human monoclonal antibodies.
    Furukawa K; Yamaguchi H; Oettgen HF; Old LJ; Lloyd KO
    J Biol Chem; 1988 Dec; 263(34):18507-12. PubMed ID: 3192544
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of growth environment on the ganglioside composition of an experimental mouse brain tumor.
    el-Abbadi M; Seyfried TN
    Mol Chem Neuropathol; 1994; 21(2-3):273-85. PubMed ID: 8086038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Developmental changes of glycosphingolipids and expression of glycogenes in mouse brains.
    Ngamukote S; Yanagisawa M; Ariga T; Ando S; Yu RK
    J Neurochem; 2007 Dec; 103(6):2327-41. PubMed ID: 17883393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generation of monoclonal antibodies specific for ganglioside lactones: evidence of the expression of lactone on human melanoma cells.
    Kawashima I; Kotani M; Ozawa H; Suzuki M; Tai T
    Int J Cancer; 1994 Jul; 58(2):263-8. PubMed ID: 8026889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Developmental stage-dependent expression of an alpha2,8-trisialic acid unit on glycoproteins in mouse brain.
    Inoko E; Nishiura Y; Tanaka H; Takahashi T; Furukawa K; Kitajima K; Sato C
    Glycobiology; 2010 Jul; 20(7):916-28. PubMed ID: 20368669
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disruption of GM2/GD2 synthase gene resulted in overt expression of 9-O-acetyl GD3 irrespective of Tis21.
    Furukawa K; Aixinjueluo W; Kasama T; Ohkawa Y; Yoshihara M; Ohmi Y; Tajima O; Suzumura A; Kittaka D; Furukawa K
    J Neurochem; 2008 May; 105(3):1057-66. PubMed ID: 18194438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunoglobulin G-class mouse monoclonal antibodies to major brain gangliosides.
    Schnaar RL; Fromholt SE; Gong Y; Vyas AA; Laroy W; Wayman DM; Heffer-Lauc M; Ito H; Ishida H; Kiso M; Griffin JW; Shiekh KA
    Anal Biochem; 2002 Mar; 302(2):276-84. PubMed ID: 11878808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kinetic and spatial interrelationships between ganglioside glycosyltransferases and O-acetyltransferase(s) in human melanoma cells.
    Sjoberg ER; Varki A
    J Biol Chem; 1993 May; 268(14):10185-96. PubMed ID: 8486686
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ganglioside composition of an experimental mouse brain tumor.
    Seyfried TN; Yu RK; Saito M; Albert M
    Cancer Res; 1987 Jul; 47(13):3538-42. PubMed ID: 3581087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tissue-specific expression of GM3(NeuGc) and GD3(NeuGc) in epithelial cells of the small intestine of strains of inbred rats. Absence of NeuGc in intestine and presence in kidney gangliosides of brown Norway and spontaneously hypertensive rats.
    Bouhours D; Bouhours JF
    J Biol Chem; 1988 Oct; 263(30):15540-5. PubMed ID: 3170597
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selection of novel peptide mimics of the GD2 ganglioside from a constrained phage-displayed peptide library.
    Horwacik I; Czaplicki D; Talarek K; Kowalczyk A; Bolesta E; Kozbor D; Rokita H
    Int J Mol Med; 2007 May; 19(5):829-39. PubMed ID: 17390090
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Melanoma-associated gangliosides in the fish genus Xiphophorus.
    Felding-Habermann B; Anders A; Dippold WG; Stallcup WB; Wiegandt H
    Cancer Res; 1988 Jun; 48(12):3454-60. PubMed ID: 3370642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Purification and structural characterization of de-N-acetylated form of GD3 ganglioside present in human melanoma tumors.
    Popa I; Pons A; Mariller C; Tai T; Zanetta JP; Thomas L; Portoukalian J
    Glycobiology; 2007 Apr; 17(4):367-73. PubMed ID: 17242043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.